"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

Governor Greg Abbott this week officially demanding reimbursement for the $11 billion shelled out by Texas taxpayers to do a ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Jan 22 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand ...

Abbott Elementary, starring Quinta Brunson, has been renewed for Season 5, the first ABC series to secure its spot on the ...

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...

Abbott Laboratories closed 3.99% below its 52-week high of $121.64, which the company reached on March 8th.

Abbott Laboratories closed $8.62 short of its 52-week high ($121.64), which the company achieved on March 8th.